Beta-Lactamase DataBase
Beta-Lactamase DataBase - Structure and Function Home Enzymes Structures Mutants Kinetics BLAST
Beta-Lactamase DataBase

Structures

Ambler
class
Protein
name
PDB
code
Resolution
(Å)
Release
date
UniProt
code
PubMed
ID
DOI
PDB
Mutations
Ligands
Space
group
Unit cell parameters
Z
value
ABPS-35GL91.502017-02-15A0A2Z4SUB5 2782743310.1038/SREP36527pdb GOL P 21 21 275.933 81.637 36.834 ♦ 90.00 90.00 90.004
ABPS-35GLA1.502017-02-15A0A2Z4SUB5 2782743310.1038/SREP36527pdb P 1 21 135.031 92.551 68.866 ♦ 90.00 92.61 90.004
ABPS-35GLB1.602017-02-15A0A2Z4SUB5 2782743310.1038/SREP36527pdb *CB4 P 21 21 270.059 92.881 34.993 ♦ 90.00 90.00 90.004
ABPS-35GLC1.602017-02-15A0A2Z4SUB5 2782743310.1038/SREP36527pdb P 21 21 269.486 97.242 34.004 ♦ 90.00 90.00 90.004
ABPS-35GLD1.702017-02-15A0A2Z4SUB5 2782743310.1038/SREP36527pdb *CB4 P 21 21 270.269 97.448 34.222 ♦ 90.00 90.00 90.004
ABPS-36AFM1.302020-01-15A0A2Z4SUB5 pdbC74Y P 21 21 2138.477 52.981 122.731 ♦ 90.00 90.00 90.004
ABPS-36AFN1.402020-01-15A0A2Z4SUB5 pdbC74Y *CB4 GOL P 21 21 2138.660 53.238 122.981 ♦ 90.00 90.00 90.004
ABPS-36AFO1.402020-01-15A0A2Z4SUB5 pdbN141D P 1 21 134.986 92.723 68.878 ♦ 90.00 92.72 90.004
ABPS-36AFP1.402020-01-15A0A2Z4SUB5 pdbN141D *CB4 ACT P 1 21 134.883 92.393 68.841 ♦ 90.00 94.27 90.004
Legend for ligands: * Ligand covalently-bound to active site residues; $ Non-covalent ligand (Michaelis complex); # Ligand coordinated to active site metal ions.

Statistics (number of structures): Overall (1530); class A (576); subclass B1 (362); subclass B2 (15); subclass B3 (96); class C (222); class D (259).

Last updated: November 16, 2022.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu